Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

Author(s):
Heissigerova, J.; Callanan, D.; Smet, M.D. de; Srivastava, S.K.; Karkanova, M.; Garcia-Garcia, O.; Kadayifcilar, S.; Ozyazgan, Y.; Vitti, R.; Erickson, K.; Athanikar, A.; Chu, K.R.; Saroj, N.; Sundaram, P.A.; Varona, R.V.; Corp-dit-Genti, V.; Buggage, R.; Cheng, Y.; Soo, Y.; Nguyen, Q.D.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-03-31
Language
English
Is part of
Ophthalmology: Journal of The American Academy of Ophthalmology (2019), Vol. 126, no. 3, p. 428-437
hdl
1887/121081
doi
10.1016/j.ophtha.2018.09.044